Funding for this research was provided by:
Innovative UK (102984)
Higher Education Innovation Fund (G.HFPS.0002)
Received: 8 June 2020
Accepted: 8 April 2021
First Online: 23 April 2021
: Dr. Mark Elliott held an honorary unpaid research position within Sweatco Ltd. (Sweatcoin) for the period of the Innovate UK funded project (May 2017–May 2018). The rest of the authors have no conflict of interest to disclose.
: The study received ethical approval by the University of Warwick Biomedical and Scientific Research Ethics Committee (BSREC) (Reference number: REGO-2017-2070). Participants gave written informed consent before filling in the questionnaires and sharing their digital data.
: Not applicable.